Plain-English translation of NCT06468566 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a new ultrasound technology called ultrasound light scattering imaging that could help doctors more accurately identify whether breast lumps are benign (harmless) or malignant (cancerous). This new technology combines regular ultrasound with special light measurements that reveal blood flow patterns and oxygen levels in breast tissue—information that may appear before visible changes occur. The goal is to reduce unnecessary biopsies and surgeries while catching breast cancer earlier.
Current ultrasound relies heavily on the doctor's skill and judgment, which can lead to unnecessary procedures and worry for patients. This new technology offers additional biological information that may help doctors make more confident and accurate diagnoses, potentially improving breast cancer detection and reducing overtreatment.
If you qualify, you will receive the new ultrasound light scattering imaging scan, likely around the time you're already scheduled for a biopsy or surgery. The imaging test itself is non-invasive and similar to a regular ultrasound—a technician will apply gel and a small probe to your breast to capture images. Your results will be compared with conventional ultrasound and your final diagnosis to help researchers understand how well the new technology works.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
China
Sponsor
Xin-Wu Cui
Collaborators
Hubei Cancer Hospital, Guangxi National Hospital
Enrollment target
~2,000 participants
Started
February 2024
Primary completion
January 2026
Age range
18 Years – 85 Years
Sex
Female only
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xiao-Feng Zhang, PhD
Xin-Wu Cui